Nutex Health Inc.
NUTX- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- SEC CIK
- 0001479681
In the last 90 days, Nutex Health Inc. insiders filed 0 open-market purchases and 1 sale; 154 institutions reported holding it in 13F filings for Q2 2026, worth $501.9M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:50 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Mar 5, 2026 | Mar 31, 2025 | Mar 28, 2024 | Mar 2, 2023 | – |
| Revenue | $875.3M | $479.9M | $247.6M | $219.3M | $18.8M |
| Cost of revenue | – | – | – | – | $14.6M |
| Gross profit | $444.3M | $196.3M | $34.8M | $13.5M | $4.15M |
| Operating expenses | $168.7M | $65.6M | $66.5M | $420.1M | $13.2M |
| Research and development | – | – | – | – | $285.9K |
| Selling, general and administrative | $51.7M | $41.9M | $33.2M | $18.0M | $12.2M |
| Operating income | $275.6M | $130.7M | -$31.8M | -$406.6M | -$9.02M |
| Interest expense | – | – | $16.3M | $12.5M | – |
| Income tax | $64.4M | $15.0M | -$5.07M | $13.1M | -$984.8K |
| Net income | $70.8M | $52.1M | -$45.8M | -$424.8M | -$13.7M |
| EPS, basic | $11.13 | $10.23 | $-0.07 | $-0.67 | – |
| EPS, diluted | $10.48 | $9.69 | $-0.07 | $-0.67 | – |
| Weighted shares, basic | 6.36M | 5.09M | 661.2M | 634.9M | – |
| Weighted shares, diluted | 6.76M | 5.49M | – | – | – |
| Margins and growth | |||||
| Gross margin | 50.8% | 40.9% | 14.0% | 6.1% | 22.1% |
| Operating margin | 31.5% | 27.2% | -12.8% | -185.4% | -48.0% |
| Net margin | 8.1% | 10.9% | -18.5% | -193.7% | -72.7% |
| Revenue growth, year over year | +82.4% | +93.8% | +12.9% | +1,066.8% | +1,085.0% |
| Net income growth, year over year | +35.9% | – | – | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Mar 5, 2026 | Mar 31, 2025 | Mar 28, 2024 | Mar 2, 2023 | – |
| Cash and equivalents | $185.6M | $40.6M | $22.0M | $34.3M | $15.3M |
| Accounts receivable | – | $232.4M | $58.6M | $57.8M | $647.3K |
| Inventory | $2.87M | $2.85M | $3.39M | $3.53M | – |
| Total current assets | $538.8M | $292.5M | $90.8M | $98.0M | $17.7M |
| Property, plant and equipment | $94.6M | $77.9M | $81.4M | $82.1M | $14.9K |
| Goodwill | $13.9M | $13.9M | $17.1M | $17.0M | $57.3M |
| Intangible assets | $21.2M | $15.5M | $20.5M | $21.2M | $10.6M |
| Total assets | $918.5M | $655.3M | $398.2M | $431.8M | $85.7M |
| Accounts payable | – | $9.61M | $18.9M | $23.6M | – |
| Short-term debt | $13.3M | $14.4M | $10.8M | $12.5M | – |
| Total current liabilities | $157.9M | $154.2M | $58.3M | $54.9M | $8.64M |
| Long-term debt | $29.2M | $22.5M | $26.3M | $23.1M | – |
| Total liabilities | $495.1M | $466.8M | $319.1M | $311.4M | $10.6M |
| Shareholders' equity | $423.4M | $188.5M | $79.1M | $120.3M | $75.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Mar 5, 2026 | Mar 31, 2025 | Mar 28, 2024 | Mar 2, 2023 | – |
| Operating cash flow | $248.1M | $23.2M | $1.26M | $50.6M | -$6.70M |
| Capital expenditures | $2.53M | $2.30M | – | $14.6M | – |
| Free cash flow | $245.6M | $20.8M | – | $36.0M | – |
| Depreciation and amortization | $20.5M | $19.0M | $17.6M | $13.1M | $4.65K |
| Stock-based compensation | $107.8M | -$129.7K | – | $189.6K | $4.03M |
| Share buybacks | $5.00M | – | – | – | – |
| Investing cash flow | -$5.24M | -$5.61M | -$11.2M | -$4.34M | $7.95M |
| Financing cash flow | -$97.9M | $1.09M | -$2.27M | -$48.1M | $14.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 12.3% | -0.0% | – | 0.1% | 21.4% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 6.86M | −3.0% | SEC |
| Aug 4, 2026 | 6.85M | – | SEC |
| Apr 28, 2026 | 6.88M | +14.9% | SEC |
| Mar 2, 2026 | 6.97M | +17.1% | SEC |
| Nov 10, 2025 | 7.07M | +30.1% | SEC |
| May 12, 2025 | 5.99M | −88.0% | SEC |
| Mar 24, 2025 | 5.95M | −99.2% | SEC |
| Nov 4, 2024 | 5.44M | −99.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Dec 31, 2020, from 13F share counts: 1-for-15 in Q2 2024 and 1-for-10 in Q3 2024.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.